InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Gaston-Dreyfus Remi, Director. Officer active across 1 companies, notably Bionik Laboratories Corp.. Cumulatively, 7 reports have been logged. The latest transaction was filed on 31 March 2022 (C). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
€668,26577,887 shares@ €8.579924.29% mcap100.0% of flow
Common Stock, par value $0.001 per share
SEC:0001104659-22-073083:0·
61,256 shares
Common Stock, par value $0.001 per share
SEC:0001104659-21-149126·
115,759 shares
Common Stock, par value $0.001 per share
SEC:0001104659-21-149127·
135,560 shares
Common Stock, par value $0.001 per share
SEC:0001104659-21-149123·
Ideal exit: 21 Dec 2021 (T+270)
61,256 shares
Common Stock, par value $0.001 per share
SEC:0001104659-21-149126:0·
115,759 shares
Common Stock, par value $0.001 per share
SEC:0001104659-21-149127:0·
135,560 shares
Common Stock, par value $0.001 per share
SEC:0001104659-21-149123:0·
Ideal exit: 21 Dec 2021 (T+270)
7 of 7 declarations
About Gaston-Dreyfus Remi
Remi Gaston-Dreyfus is a Board Member at Bionik Laboratories Corp. He actively participates in the governance of the company, bringing his expertise in the medical technology sector. His role includes overseeing operations and contributing to the company's strategy. Through his experience, he helps guide Bionik towards sustainable growth and innovation.
